chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 19-Feb-2022; Patient received vaccine past its 30 days expiry date; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient received vaccine past its 30 days expiry date) and PRODUCT STORAGE ERROR (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 19-Feb-2022) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 066H21A) for COVID-19 vaccination.     The patient's acute illness at the time of vaccination and up to 1 month before and chronic or long standing health conditions was unknown. Other vaccines received on the same day as of Moderna or other vaccines received one month prior to any dose of Moderna was unknown.     On 19-Feb-2022 at 11:01 AM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 19-Feb-2022 at 11:01 AM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient received vaccine past its 30 days expiry date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 19-Feb-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient received vaccine past its 30 days expiry date) and PRODUCT STORAGE ERROR (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 19-Feb-2022) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Ethnicity was given as private. The patient was given booster dose on 19-Feb-2022 at 11:01:54. The manufacturer expiry date was on 04-Apr-2022. Prescriptions, over the counter medications, dietary supplements or herbal medicines being taken at the time of vaccination and or at the time of adverse event was unknown. Treatment information was not provided.   This case was linked to MOD-2022-542869 (Patient Link).
The youth who was 11 at the time of the vaccine was given the dosage for ages 12 and up.   It was unknown until a representative for our corporate billing department contacted us about being unable to bill for the vaccine and not understanding the details.  There have been no known  adverse reactions or events related to the injection.  It has been reported to the primary care physician for the youth.
6/22: 85 y/o male admitted to hospital from ED with complaints of fatigue, shortness of breath, and generalized weakness. Received 2nd dose of COVID-19 Moderna vaccine yesterday (6/21). admitted to med-tele unit. COVID-19 positive. Previous COVID infection in Dec 2020 s/p treatment with remdesivir and convalescent plasma therapy.  6/23-6/25: improvement in breathing and fever. 6/26: patient found to be bradycardic with heart rate as low as 30s and recurrent pauses. Likely due to recent increased dose of Coreg. Coreg held and Dopamine drip started and patient transferred to ICU. 6/27: remains on dopamine; HR stable. on 2L via nasal cannula. 6/28-7/4: afebrile. still on supplemental oxygen via NC. dopamine drip on hold and then discontinued on 6/29. 7/5: acceptable saturations on room air. will d/c to subacute rehab. denies chest pain/cough.  7/6: discharged.
Large red, hot hive: 3 x 5"; large, painful lump the size of an egg at injection sight; flu like symptoms; was sick for 10 days. It took about 12 days for the redness and lump to dissipate. I do have reaction to flu shots, but not this severe.
Administration error: A 31-year-old female patient receives booster doses without meeting the guidelines for the administration of booster doses established by the CDC and Department of Health.
Migraine shortly after vaccine, Next day starting when I woke up: fever 102 which lasted 2 hours; sore and very swollen arm lasted 48+ hours; back pain lasted 48 hours; skin pain lasted 24 hours; swollen feet with bruising lasted 48 hours, bruising and pain for a week plus (still happening); numbing and tingling in jaw lasted 1 hours; upset stomach with diarrhea lasted 48 hours;
stroke; Brain bleed; Brain blood clot; This is a spontaneous report from a contactable consumer via a Pfizer sponsored program named Corporate (Pfizer) Social Media Platforms. A 53-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration, administered in Arm Left on 11Mar2021 13:15 as single dose for covid-19 immunisation.  Medical history reported as none.  The patient's concomitant medications were not reported.  The patient experienced brain blood clot on 25Mar2021 08:00 , stroke and brain bleed on an unspecified date.  The patient was hospitalized for brain blood clot, stroke, brain bleed for 7 days.  Therapeutic measures were taken as a result of brain blood clot, stroke, brain bleed included Ventillator.  The patient died on 02Apr2021.  An autopsy was not performed. The outcome of events was fatal. No other vaccine in four weeks; No covid prior vaccination.  Information on the lot/batch number has been requested.; Reported Cause(s) of Death: Brain blood clot; stroke; Brain bleed
In January 2023, my husband had pneumonia and type A influenza. In early February 2023, I felt like I had a chest cold. I was coughing, sneezing, and felt lousy. It wouldn't go away, so a couple of weeks later, I went to my physician. I was diagnosed bronchitis or upper respiratory infection, and he prescribed me prednisone (40mg) and Levaquin. I went back to the doctor ten days later, because my symptoms had not improved at all; in fact, they had steadily gotten worse. He had me undergo a chest X-ray, and pneumonia was detected. I was then prescribed erythromycin and bromphen/pseudo/dextro HBR syrup. I am now slowly getting better. At the time of this writing, I am about 90% better, but the explained that it could take weeks for me to completely recover. I still have a productive cough, but it's much better now than it was at the beginning of the illness. We regularly take COVID-19 tests, and at this point, I have never had a positive result.
pt recv vax & devel diarrhea;approx 3mo post vax pt devel bumps under the skin & a staphylococcal infect of the instep;since AUG94 pt exp a 40-pound weight loss & many med problems;
pt recvd 2 doses of Engerix-B on 28JAN91 & 21FEB91 & following 1st inject pt devel upper resp sx, aches, cough, fatigue, flu sx & t101; following 2nd inject devel similar sx but in lesser degree; off work 3 days; 3rd dose of vax not given;
2 COVID tests- both positive; 2 COVID tests- both positive; Booster; This is a spontaneous report from a contactable consumer (patient). This patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), dose 1 via an unspecified route of administration on Mar2021 (Batch/Lot number was not reported) as Dose 1, single, dose 2 via an unspecified route of administration on Mar2021 (Batch/Lot Number: Not known) as Dose 2, single and dose 3 via an unspecified route of administration on 28Oct2021 (Batch/Lot Number: Not known) as DOSE 3 (BOOSTER), SINGLE for COVID-19 immunisation. The patient took 2 COVID tests on 04Nov2021, both indicated positive. The patient had mild symptoms - incl sore throat and cough. Outcome of the events was unknown.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
Pt recv vax on 11/3/98; on same day pt exp headache, diarrhea x36 hr, red, raised, hot vax site area.
my child developed myocarditis. we are STILL fighting a battle of heart inflammation with a string of side effects?elevated heart rate, chest pains, and now mitral valve prolapse. this has been a nightmare. we?re waiting for her next round of MRIs to see if the inflammation has gone down so she can resume a normal life again.
pt w/fever 104.5 ax/irritability 12hrs p/vax;high pitched crying but consolable by rocking;fever dec w/APAP;no szs;pt seen next day exam nl x/fever;observed for 1hr pt playing/taking bottle well
Diarrhea; This is a spontaneous report from a contactable Consumer (Patient). A 73-years-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE: Solution for injection, Batch/Lot Number: EL9269 Pa NO: 721533), via an unspecified route of administration, administered in Arm Right on 07Feb2021 15:00 as single dose for covid-19 immunisation. Medical history included prostate cancer and type 2 diabetes mellitus from an unknown date and unknown if ongoing. Concomitant medications included metformin 750 mg twice daily, atorvastatin 40mg once daily, canagliflozin (INVOKANA [CANAGLIFLOZIN]), 100 mg once daily, ascorbic acid, betacarotene, cupric oxide, manganese sulfate, selenium, tocopheryl acetate, ubidecarenone, zinc oxide (COQ10 [ASCORBIC ACID;BETACAROTENE;CUPRIC OXIDE;MANGANESE SULFATE;SELENIUM;TOCOPHERYL ACETATE UBIDECARENONE;ZINC OXIDE]) 300 mg once daily and fish oil 1000mg. On 08Feb2021 12:00, the patient experienced diarrhea. The action taken in response to the event for BNT162B2 was not applicable. The outcome of event was recovered.
fever; chills; terrible headache; joint pain/severe joint pain; general malaise; not interested in food and is just sick; not interested in food and is just sick; redness reaction; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team.  An 81-year-old male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 07Nov2022 as dose number unknown (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Primary Immunization series complete; unknown manufacturer), for COVID-19 immunization. The following information was reported: CHILLS (non-serious) with onset 08Nov2022, outcome "not recovered"; PYREXIA (non-serious) with onset 08Nov2022, outcome "not recovered", described as "fever"; MALAISE (non-serious) with onset Nov2022, outcome "not recovered", described as "general malaise"; ARTHRALGIA (non-serious) with onset Nov2022, outcome "not recovered", described as "joint pain/severe joint pain"; DECREASED APPETITE (non-serious), ILLNESS (non-serious) all with onset Nov2022, outcome "unknown" and all described as "not interested in food and is just sick"; VACCINATION SITE ERYTHEMA (non-serious) with onset Nov2022, outcome "unknown", described as "redness reaction"; HEADACHE (non-serious) with onset Nov2022, outcome "not recovered", described as "terrible headache". The events "fever", "chills", "terrible headache", "joint pain/severe joint pain", "general malaise", "not interested in food and is just sick" and "redness reaction" required emergency room visit. Relevant laboratory tests and procedures are available in the appropriate section.  Additional information: Caller is calling about the Pfizer COVID-19 Bivalent vaccine. She reported that her husband had the vaccine on a week ago, last Monday. By the next day, he developed fever, chills. Also having "terrible headache", joint pain, gets fever at night and general malaise. She said that her husband is "not getting any better." She wants to know if there is anything that mitigates this, if this is an auto-immune reaction instead of just having to wait. Mentioned that the 10 days seem long because such in redness reaction which may last 1-2 days, but no further information found in regard to causes and how long side effects experienced by patient last. By Thursday, her husband's temperature was 101.8, by Friday it was not better. They called # and went to the ER and the tests did not show anything concerning. Her husband is a healthy 81-year-old. Now they are on day 10 and have talked their general doctor and he just told them to call back if he is not better by Monday. Her husband still has a terrible headache and severe sore joint pain. Her husband is not really having a fever anymore, but will still run a fever at night to 99.1 and has general malaise. He was not interested in food and is just sick.  The information on the batch/lot number for BNT162b2, BNT162b2 omi ba.4-5 has been requested and will be submitted if and when received.
new onset of erythematous pruritic rash that started on scalp and spread throughout body that started 3/31/21. Symptom of Erythema multiforme that started 2 weeks after vaccine, no other etiology found.
I tested positive for COVID-19 on 20Sep21 after being fully vaccinated since April 2021.; I tested positive for COVID-19 on 20Sep21 after being fully vaccinated since April 2021.; This is a spontaneous report from a contactable 50-year-old male consumer (pfizer colleague/patient) reported for himself.   A 50-years-old male patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA vaccine, Solution for injection), intramuscularly, administered in arm left on 07Apr2021 (Batch/Lot Number: EW0153) as dose 2, single (at the age of 50-year-old) and first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA vaccine, Solution for injection) intramuscularly, administered in arm left on 15Mar2021 (Batch/Lot Number: EP6955) as dose 1, single for covid-19 immunisation (at the age of 50-year-old). The patient medical history was reported as no. There were no concomitant medications. Facility where the most recent COVID-19 vaccine was administered was pharmacy or drug Store. The patient did not receive any other vaccines within 4 weeks prior to the Covid 19 vaccine. The patient did not receive any other medications within 2 weeks of vaccination. The patient had not been diagnosed with COVID-19 prior to vaccination. The patient has been tested for Covid-19 since the vaccination through nasal swab test on 20Sep2021 and resulted with positive. The patient had no known allergies. On 20Sep2021, the patient reported that he tested positive for COVID-19 on 20Sep21 after being fully vaccinated since April 2021. The patient visited emergency room/department or urgent care. The patient not received treatment. The patient underwent lab tests and procedures which included sars-cov-2 test: positive on 20Sep2021. The outcome of the events was recovering.
NASAL CONGESTION, NAUSEA, DIARRHEA, AND FATIGUE.  GIVEN MEDS TO TREAT SYMPTOMS SENT HOME SICK FOR 24 HOURS
L arm upper deltoid area swollen and tender to touch.  Pain with range of motion.   Instructed parent to watch area for increased signs of infection.   Flu injection administered 10/3/08 Pt seen 11/7/2008 for persistent reaction.
pt recvd vax & w/in 24hrs p/vax pt exp nausea & dizziness;sx resolved w/o treatment;
Pyloric valve cramped....5 hours of gutshot-like pain until I found a video on how to calm the cramping and then manually emptying the stomach.   Then, 2 days of flu symptoms....headache,  intense bodyache, clogged sinuses, no energy, dry cough.   I had never experienced pyloric valve contraction before, nor had I ever experienced adverse reactions to a flu shot. Corona virus symptoms began 08/08/2020...positive test results confirmed 08/11/2020.   Sickness abated on 08/19/2020, but am still not back up to full stamina.
I received the flu, pneumonia, and shingles shot last week. The next day my arms were so sore, I could not lift them. On Friday I began running a low grade fever and a red rash along with swelling began spreading all over the arm where I received the flu and pneumonia shots. Saturday my arm began running a fever and the rash continued to spread. I put ice packs on the area and started taking BENADRYL. After about 2 days it began to subside. The shingles vaccination was in the other arm which continues to be sore and slightly red. I get the flu shot every year and have never had a bad reaction. This was the first time I have ever gotten the pneumonia shot.
Employee reports that she "had a grand mal seizure" at approx 7:15 pm last evening. She states that she did not seek treatment, she "went to bed". States that she "is fine" today. Last TD vaccine was 205, Medical DX: AVM, Seizure disorder.
From initial information received on 21Apr04 from a health care professional regarding an adverse event occurring, it was reported that a 51 year old female pt received her third pre exposure Imovax Rabies vaccination, lot number W14193, on 04Mar04. That same day, the pt experienced a full body rash (the reporter was unaware of the type of rash) and thickening of the throat. She was treated by a physician with Benadryl and a prednisone pack. The recovery status of the pt was not reported. From additional information received on 18May04 it was reported that the pt also received her third dose of Twinrix vaccine, lot number HAB235A4, admin IM in physician and vaccine administrator were provided. No further information is anticipated, this case is considered closed. The reporter of this case is the same reporter of case 200401720.
Began developing chills, shivering at 7 pm. Continued until 3am accompanied by fever to 101, nausea, headache. Fever abated by 11 am as well as nausea and headache.
This case was reported by a nurse via call center representative and described the occurrence of erythematous rash in a 18-month-old male patient who received KINRIX (batch number E72T3, expiry date 25th April 2020) for prophylaxis. On 15th August 2018, the patient received KINRIX. On 15th August 2018, unknown after receiving KINRIX, the patient experienced inappropriate age at vaccine administration. On 16th August 2018, the patient experienced erythematous rash, papular rash and itchy rash. On an unknown date, the outcome of the erythematous rash, papular rash, itchy rash and inappropriate age at vaccine administration were unknown. It was unknown if the reporter considered the erythematous rash, papular rash, itchy rash and inappropriate age at vaccine administration to be related to KINRIX. Additional details reported as follows: The patient received KINRIX which was given to an 18 month old, which led to inappropriate age at vaccine administration. One day after vaccination, the patient experienced red bumpy, itchy rash on his legs, trunk and diaper area.
mom states pt had severe screaming for the 1st 3-8 hrs; p/vax; no fever consistent for 1st 3 hrs then intermittent for next 5 hrs;
Client experienced a vasovagal event immediately after receiving vaccine. Prior to this immunization had received BEXSERO #1, and Hepatitis A #2. Fainted for 3-5 seconds, helped to a reclining position. BP 90/50. Vomited, then felt better, about 15-20 later. Retained fluids given. BP 110/60..escorted home with parent. Total time recovering about 35 minutes.
A report has been received from a physician concerning, female subject, who had been receiving Nasal FLUMIST. FLUMIST started on an unknown date. It was reported that physician cut herself when administering FLUMIST. At the time of reporting, the event of physician cut herself when administering FLUMIST was improving. The report was considered to be non-serious. Summary of follow-up information received by AstraZeneca/MedImmune 15-Jan-2013 from Physician: No new information to add in this case. Coding of physician cut herself when administering FLUMIST was changed to accidental injury. Based on this investigation, no root cause can be determined. All inspection results were within specified limits. The evaluation of the return sample confirms the reported complaint. Summary of follow-up information received by AstraZeneca/MedImmune 25-Feb-2013: exp date updated, complaint report summary added.
Facial tics and it's getting progressively worse; Side effects after the vaccine; This spontaneous case was received on 13-Dec-2022, from other non-healthcare professional (consumer) (reference number: SEQW22-06435) and concerned a 16-year-old male patient.  The patient's medical history was not reported. The patient was not taking any concomitant medications.  On 30-Nov-2022, the patient was vaccinated with Flucelvax Quadrivalent (influenza vaccine inact sag 4v; dose, route of administration and anatomical location: not reported), for prevention of seasonal influenza. The batch number and expiry date were not reported.  On 30-Nov-2022, the same day, an unreported amount of time after receiving Flucelvax Quadrivalent, the patient experienced side effects (not specified). Furthermore, the patient suffered facial tics and it was getting progressively worse.   The outcome of the events was not reported.  The reporter did not provide a causality assessment.  Company comment: A 16-year-old male patient experienced adverse event following vaccination and facial tics on the same day, an unreported amount of time after vaccination with Flucelvax Quadrivalent vaccine. The patient's medical history was not reported. The patient was not taking any concomitant medications. Information regarding the related diagnostic findings was not provided. Causality is assessed as possibly related for both events based on plausible temporal relationship.; Sender's Comments: A 16-year-old male patient experienced adverse event following vaccination and facial tics on the same day, an unreported amount of time after vaccination with Flucelvax Quadrivalent vaccine. The patient's medical history was not reported. The patient was not taking any concomitant medications. Information regarding the related diagnostic findings was not provided. Causality is assessed as possibly related for both events based on plausible temporal relationship.
No adverse effects were reported in the patient; Patient was inadvertently given third dose of VAQTA; Patient was inadvertently given third dose of VAQTA; This spontaneous report was received from a healthcare professional referring to a patient of unknown age and gender. The patient's concurrent conditions, medical history, drug allergies/reactions and concomitant medications were not reported. On an unknown date, the patient was vaccinated with hepatitis a vaccine, inactivated(VAQTA) 25/0.5 vial, dose 3 lot # S007770, expiry date: 24-JUL-2020 (dose/frequency, route were not reported) for prophylaxis. On 26-AUG-2019 the patient was inadvertently given a third dose of hepatitis a vaccine, inactivated(VAQTA) extra dose administered and inappropriate schedule of product administration. On an unknown date, the patient experienced no adverse event. The outcome of extra dose administered, no adverse event and inappropriate schedule of product administration was unknown.
Upper Right arm slightly swollen, hot to touch, pain with shoulder abduction. At site of varicella injection.
Information has been received from a registered nurse regarding a patient of unknown age and gender. On 09-SEP-2013 at 07:30, ZOSTAVAX lot # J003360 was exposed to an exact T not recorded but noted as eual to or >12C for an estimated total time out of range of 72 hours. On 10-SEP-2013 at 17:30, ZOSTAVAX lot # J003360 was exposed to -13C for an estimated total time out of range of 10 hours. On 16-SEP-2013 at 17:30, ZOSTAVAX lot # J003360 was exposed to 11C for an estimated total time out of range of 10 hours. On 25-SEP-2013 at 07:30, ZOSTAVAX lot # J003360 was exposed to 11C for an estimated total time out of range of 14 hours. On 07-OCT-2013 at 07:30, ZOSTAVAX lot # J003360 was exposed to an exact T not recorded but noted as equal to or <12C for an estimated total time out of range of 42.5 hours. On 08-OCT-2013, the patient was vaccinated with an out of range dose of ZOSTAVAX (dose and route administration were not provided) (Lot number J003360, Exp. Date: 21-JUN-2014). No adverse experience had been reported. This is one of 182 reports from the same source. Additional information has been requested.